Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation
Author:
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Eye
- Vol. 15 (3) , 407-412
Abstract
Subfoveal choroidal neovascularisation (CNV) is a major cause of visual disability, with age-related macular degeneration (AMD) the commonest cause. Confluent laser to CNV significantly reduces severe visual loss but the profound visual loss after treatment of subfoveal lesions and the high recurrence rate has meant its restriction to extrafoveal lesions. Developed initially as a treatment for cancers, photodynamic therapy (PDT) has been shown to successfully close CNV in the eye. Large international randomised placebo-controlled studies of the safety and efficacy of PDT with verteporfin are under way. The Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) study has demonstrated a reduction of visual loss in treated patients with any classic CNV. Subgroup analysis showed a greater benefit in predominantly classic lesions (p < 0.001, NNT: 3.6), increasing further for lesions with no occult component, roughly equivalent to pure classic (p < 0.01, NNT: 2.2) A significant benefit at 12 months has been shown in patients with CNV secondary to myopia in the Verteporfin in AMD (VIP) trial, but no benefit in pure occult lesions. Further research is required to establish cost-effectiveness and appropriate referral patterns in the UK and optimise treatment strategies. Further data are awaited from TAP/VIP. At present verteporfin PDT is indicated in eyes with subfoveal predominantly classic CNV secondary to AMD with visual acuity of 6/60 or better and lesions < 5400 µm in diameter. Juxtafoveal lesions meeting the above criteria and CNV secondary to pathological myopia should also be considered for treatment. The efficacy of treatment of larger lesions, juxtapapillary CNV, occult/no classic with high-risk characteristics (HRC) and CNV from other causes remains unclear. The treatment of minimally classic lesions and those with occult/no classic without HRC is not indicated.Keywords
This publication has 25 references indexed in Scilit:
- The Prevalence of Age-related Maculopathy in the Rotterdam StudyOphthalmology, 1995
- Laser Photocoagulation for Juxtafoveal Choroidal NeovascularizationArchives of Ophthalmology (1950), 1994
- Visual Outcome After Laser Photocoagulation for Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1994
- Laser Photocoagulation of Subfoveal Neovascular Lesions of Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1993
- Prevalence of Age-related MaculopathyOphthalmology, 1992
- Laser Photocoagulation of Subfoveal Neovascular Lesions in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1991
- Argon Laser Photocoagulation for Neovascular MaculopathyArchives of Ophthalmology (1950), 1991
- New trends in photobiologyJournal of Photochemistry and Photobiology B: Biology, 1989
- Age-related macular degenerationSurvey of Ophthalmology, 1988
- Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study Group.British Journal of Ophthalmology, 1982